Danaher Corporation (DHR) — RQD Stock Rating Cockpit

$236.98 +1.24% NYSE • Public Delayed / 60s Snapshot

Danaher Corporation (DHR) receives a Roarable Rating of D (Sell) and flashes a Red SELL / AVOID warning (65/100 RQD Confidence). Our SEC filing scanner spotted paper earnings outpacing real operating cash flow (-3.2% (NI vs OCF)) while unpaid customer invoices grew—a classic sign to step aside until cash flow catches up.

ROARABLE D • SELL / AVOID Cap $166.72B
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
RQD QUANT TACHOMETERSELL / AVOID • D
025507510065
JEV AI Jury Split (Battleground)
Cash
SEC
Whale
5-PILLAR SNOWFLAKE RADARRw D+ · Rk D
Cash (13)Whales (10)SEC (8)Macro (17)CEO (12)
Each axis scored 0–20
12M PRICE TARGET CONE+3.1% Base Target
$288 Bull$244 Base$191 Bear
🔴 SUNDAY NIGHT PREP • 7:00 PM ET
WHALE OPTIONS TUG-OF-WAR:57% Call Buyers ($17.2M)
43% PutsMax Pain: $232.00
RSI-14 MOMENTUMBULLISH MOMENTUM
58.130 Oversold · 70 Hot
ALTMAN-Z SHIELDFORTRESS SAFE (>3.0)
3.85>3.0 Fortress Safe
PIOTROSKI F-SCOREHIGH QUALITY (7–9)
7 / 99-Pt Accounting
52-WEEK LASER RANGE93% OF RANGE
L: $161$236.98H: $243
1. Money & Cash Health● RED FLAG
Are profits real cash in the bank?

Warning: Paper profits outpaced real cash collected while unpaid invoices rose—classic earnings quality red flag.

Factor Grade: DRQD 13 / 20
2. Big Money & Insiders● NEUTRAL
Are whales & executives buying or selling?

Big funds and company insiders are mostly holding steady without aggressive buying or panic selling.

Factor Grade: C-RQD 22 / 40
3. Hidden Risks & Market Weather● WARNING
SEC fine-print scan & interest-rate fit

Our SEC fine-print scanner flagged elevated accounting or executive-hedging risk combined with interest-rate headwinds.

Factor Grade: DRQD 30 / 40
MULTI-MODEL JEV QUANT JURY DELIBERATION

JEV AI Jury Split (Battleground) on DHR

Cash & Moat Bull AI
ROIC & Free Cash Flow Model
NEUTRAL (65)

6.1% ROIC with 59.1% gross margin and 3.15% FCF yield.

SEC Forensic Auditor AI
10-K Accruals & Altman-Z Guard
BEARISH (36)

Flagged cash-conversion divergence or elevated filing risk disclosures.

Whale & Macro Hawk AI
Options Skew, 13F & Fed NetLiq
NEUTRAL (65)

Put/Call 0.74x with 22/40 institutional & insider flow.

Bull Case: Why Buyers Like DHR
  • ✓Established market leader in Industrials with deep daily trading liquidity.
Bear Case: What Could Go Wrong
  • !Headline earnings grew much faster than real operating cash flow—watch out for profit revisions.
  • !Priced at 46x earnings—high expectations leave less room for a lukewarm quarter.
🔴 SUNDAY NIGHT PREP • 7:00 PM ETHosted Live by Perry Belcher & Guest Forensic Quant Desk

Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring DHR)

  • ✓Live walkthrough of DHR's RQD Radar, SEC cash-conversion gap & downside levels
  • ✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
  • ✓Includes instant 24/7 email alert whenever any of your stocks flip to Red
RQD INSIDER CLUB UPGRADE$49/YEAR
Want Plain-English AI Custom Indicators, Daily Pro Trader Video Clips & SMS Crash Alerts?
DHR // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +29.77%▲ ASCENDING CHANNEL
2026-10-30O $238.5H $238.5L $230.5C $232.2VOL 3.75M
RES: $256.1SUP: $173.6SMA50: $218.9SMA200: $201.1
$243.9$221.4$198.9$176.4$154.0RES $256.1SUP $173.6$232.22026-04-302026-06-152026-07-312026-09-162026-10-30
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

DHR Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)
34.2%/yr Implied 5Y Growth

vs. +2.9% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on DHR today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →
DHR → NVO Analyst Hypothesis
Novo Nordisk $6B+ annual API manufacturing expansions utilize downstream purification chromatography resins and single-use filtration consumables where Danaher Cytiva and Pall hold leading bioprocess share.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for DHR today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DHR Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Should I buy, hold, or sell DHR stock right now?

Danaher Corporation (DHR) currently earns a Roarable Rating of D (Sell — SELL) with 65/100 RQD Confidence. Accounting Warning: Paper earnings outpaced operating cash flow (-3.2% (NI vs OCF)) as receivables rose.

What is DHR's 12-month price target and RQD AI Jury consensus?

DHR's 12-month base price target is $244.44 (range $190.66 to $288.44), backed by transparent SEC XBRL cash-flow, Form 4 insider, and CBOE options flow analysis.